Nicox provides 2018 Outlook and 2017 Estimated Financial Results
Mar 06, 2018 06:31 am UTC| Business
Press Release Nicox provides 2018 Outlook and 2017 Estimated Financial Results VYZULTATM (latanoprostene bunod ophthalmic solution), 0.024%, marketed by partner Bausch + Lomb in the U.S. since ...
ERYTECH to Host Fourth Quarter and Full Year 2017 Conference Call and Business Update
Mar 06, 2018 06:30 am UTC| Business
ERYTECH to Host Fourth Quarter and Full Year 2017 Conference Call and Business Update Lyon (France), March 6, 2018 - ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical...
Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Argentina by Grupo Biotoscana
Mar 06, 2018 06:16 am UTC| Business
First launch in Latin America Basel, Switzerland, March 06, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that partner Grupo Biotoscana S.L. ("GBT") has launched Basilea's hospital antibiotic Zevtera®...
Mar 06, 2018 06:00 am UTC| Business
AMSTERDAM, The Netherlands, March 06, 2018 -- IBFD, the centre of expertise on cross-border taxation, announced today that it has entered into a collaboration and distribution agreement with Tax Analysts, a leading...
Telstra Taps Aria Systems for Cloud-Based Billing and Monetization
Mar 06, 2018 05:10 am UTC| Business
SAN FRANCISCO, March 06, 2018 -- Aria Systems, the leader in helping enterprises grow subscription- and usage-based revenue, today announced that Telstra (ASX:TLS), Australia’s leading telecommunications and technology...
Arcturus Therapeutics Calls on Proposed Director Nominees to Respond to Constructive Board Outreach
Mar 06, 2018 04:54 am UTC| Business
SAN DIEGO, March 05, 2018 -- Arcturus Therapeutics Ltd. (NASDAQ:ARCT), a leading RNA medicines company, today issued the following statement regarding the previously announced process for members of the Company’s Board...
Immutep Announces United States Patent Grant for IMP701 Antibody
Mar 06, 2018 03:54 am UTC| Business
SYDNEY, Australia, March 05, 2018 -- Immutep Limited (ASX:IMM) (NASDAQ:IMMP) (“Immutep”, the “Company”) announces the grant of patent no. 9,908,936 entitled “Antibody molecules to LAG-3 and uses thereof” by the United...
FxWirePro- Major Economic events today